Sort
48,018 grants matching “immunotherapy”
Immunogenicity & efficacy of chimeric flu virus expressing Ab42 B cell epitope
$373,999Michael G Agadjanyan · Institute For Molecular Medicine · R01 · FY2012 · NS
Immunogenicity & efficacy of chimeric flu virus expressing Ab42 B cell epitope
$373,999Michael G Agadjanyan · Institute For Molecular Medicine · R01 · FY2011 · NS
Adoptive T cell Therapy of Melanoma Targeting NY-ESO-1
$373,963Cassian Yee · Fred Hutchinson Cancer Research Center · R01 · FY2012 · CA
Novel ways to prevent upper GT infection
$373,947Kathleen A. Kelly · University Of California Los Angeles · R01 · FY2012 · AI
The novel role of the immunoproteasome subunit LMP7 in allo-immunity and T cell exhaustion
$373,910Jamil Azzi · Brigham And Women'S Hospital · R01 · FY2019 · AI
The novel role of the immunoproteasome subunit LMP7 in allo-immunity and T cell exhaustion
$373,871Jamil Azzi · Brigham And Women'S Hospital · R01 · FY2020 · AI
eDyNAmiC-TEXASSW
$373,862Zhijian J Chen · Ut Southwestern Medical Center · OT2 · FY2022 · CA
The novel role of the immunoproteasome subunit LMP7 in allo-immunity and T cell exhaustion
$373,830Jamil Azzi · Brigham And Women'S Hospital · R01 · FY2021 · AI
T cell homeostasis
$373,817Stephen C Jameson · University Of Minnesota · R01 · FY2016 · AI
Project 3: Chronic interferon and bile acid signaling as drivers of immunosuppression in age-related liver cancer
$373,817Susan M Kaech · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2021 · AG
The novel role of the immunoproteasome subunit LMP7 in allo-immunity and T cell exhaustion
$373,789Jamil Azzi · Brigham And Women'S Hospital · R01 · FY2022 · AI
Targeting cellular double-stranded RNA homeostasis in breast cancer
$373,774Cecil Han · Georgetown University · R01 · FY2025 · CA
Targeting cellular double-stranded RNA homeostasis in breast cancer
$373,774Cecil Han · Georgetown University · R01 · FY2022 · CA
Targeting cellular double-stranded RNA homeostasis in breast cancer
$373,774Cecil Han · Georgetown University · R01 · FY2021 · CA
Microfluidic Precision Engineered Artificial Antigen Presenting Cells for Cancer Immunotherapy
$373,718Abraham P Lee · University Of California-Irvine · R33 · FY2023 · CA
Determining treatment sensitivity in B cell lymphoma by novel microfluidics-based NK cell immunogenicity platform
$373,709Tania Tali Konry · Northeastern University · R33 · FY2019 · CA
Clinical Significance and Mechanism of Action of Exosomal microRNAs in Neuroblastoma chemoresistance
$373,701Muller Fabbri · Children'S Research Institute · R01 · FY2022 · CA
Regulation of repetitive elements in cancer by P53 and epigenetic mechanisms
$373,701Katherine B Chiappinelli · George Washington University · R37 · FY2022 · CA
Analysis of peripheral tolerance in vivo
$373,690Marc K. Jenkins · University Of Minnesota · P01 · FY2015 · AI
Biofilm Formation by Pneumocystis
$373,646Melanie T Cushion · University Of Cincinnati · R01 · FY2011 · AI
Requirement for sensitive T cell response to antigen
$373,644Michael L Dustin · New York University School Of Medicine · R37 · FY2012 · AI
Autografting for Lymphoma
$373,636Sandra J. Horning · Stanford University · P01 · FY2008 · CA
The Tetrazine Ligation for Efficient 18F Labeling and Pretargeted Imaging/Radioth
$373,631Zibo Li · University Of Southern California · R01 · FY2013 · EB
CELLULAR MECHANISMS OF SEPSIS AND ORGAN FAILURE
$373,627Richard Samuel Hotchkiss · Washington University · R01 · FY2010 · GM
Eradication of Escaped Variant Tumor Cells for Cancer Immunotherapy
$373,617Yong Lu · Wake Forest University Health Sciences · R01 · FY2021 · CA